52 Week LowKDL Biotech has hit 52wk low of Rs 1.61 on BSE
52 Week LowKDL Biotech has hit 52wk low of Rs 1.67 on BSE
AnnouncementsKDL Biotech gets extension to hold AGM
52 Week LowKDL Biotech has hit 52wk low of Rs 1.70 on BSE
52 Week LowKDL Biotech has hit 52wk low of Rs 1.72 on BSE
AnnouncementsKDL Biotech: Updates on workers strike
AnnouncementsKdl Biotech: Yogendra Chauhan ceases to be director
|Company Name||Last Price||%
|Dr Reddys Labs||2443.70||-0.29||2545.00||1764.00||41,567.27|
|Mar' 13||Dec' 12||Sep' 12||Mar' 12|
|No Mutual Funds Holding the share|
KDL Biotech is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 4.73 crore.The company has reported a standalone sales of Rs 5.13 crore and a Net Loss of Rs 3.61 crore for the quarter ended Mar 2013.
The company management includes Nalin Bamzai - Managing Director, Rajesh Agrawal - Director - Technical, Sanjay Sinha - Director, Avantika Varma - Additional Director.
It is listed on the BSE with a BSE Code of 532291 and the NSE with an NSE Code of KOPDRUGS.
Its Registered office is at Village Savroli, Taluka: Khalapur., Raigad District,Maharashtra - 410202.
Their Registrars are Bigshare Services Pvt. Ltd.